Napolitano M - Search Results

1

The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.

Normanno N, De Luca A, Maiello MR, Campiglio M, Napolitano M, Mancino M, Carotenuto A, Viglietto G, Menard S. Normanno N, et al. Among authors: napolitano m. J Cell Physiol. 2006 May;207(2):420-7. doi: 10.1002/jcp.20588. J Cell Physiol. 2006. PMID: 16419029

2

Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1).

Baldassarre G, Bruni P, Boccia A, Salvatore G, Melillo RM, Motti ML, Napolitano M, Belletti B, Fusco A, Santoro M, Viglietto G. Baldassarre G, et al. Among authors: napolitano m. Oncogene. 2002 Mar 7;21(11):1739-49. doi: 10.1038/sj.onc.1205226. Oncogene. 2002. PMID: 11896605

3

Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.

Motti ML, Califano D, Baldassarre G, Celetti A, Merolla F, Forzati F, Napolitano M, Tavernise B, Fusco A, Viglietto G. Motti ML, et al. Among authors: napolitano m. Carcinogenesis. 2005 Jun;26(6):1021-34. doi: 10.1093/carcin/bgi050. Epub 2005 Feb 17. Carcinogenesis. 2005. PMID: 15718252

4

AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib.

Maiello MR, D'Alessio A, De Luca A, Carotenuto A, Rachiglio AM, Napolitano M, Cito L, Guzzo A, Normanno N. Maiello MR, et al. Among authors: napolitano m. Breast Cancer Res Treat. 2007 May;102(3):275-82. doi: 10.1007/s10549-006-9340-7. Epub 2006 Sep 27. Breast Cancer Res Treat. 2007. PMID: 17004112

5

Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cells.

D'Alessio A, De Luca A, Maiello MR, Lamura L, Rachiglio AM, Napolitano M, Gallo M, Normanno N. D'Alessio A, et al. Among authors: napolitano m. Breast Cancer Res Treat. 2010 Sep;123(2):387-96. doi: 10.1007/s10549-009-0649-x. Epub 2009 Nov 28. Breast Cancer Res Treat. 2010. PMID: 19946741

6

Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol.

Ottaiano A, Scala S, Normanno N, Napolitano M, Capozzi M, Rachiglio AM, Roma C, Trotta AM, D'Alterio C, Portella L, Romano C, Cassata A, Casaretti R, Silvestro L, Nappi A, Tafuto S, Avallone A, De Stefano A, Tamburini M, Picone C, Petrillo A, Izzo F, Palaia R, Albino V, Amore A, Belli A, Pace U, Di Marzo M, Chiodini P, Botti G, De Feo G, Delrio P, Nasti G. Ottaiano A, et al. Among authors: napolitano m. BMC Cancer. 2019 Sep 9;19(1):899. doi: 10.1186/s12885-019-6109-z. BMC Cancer. 2019. PMID: 31500586 Free PMC article.

7

In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies.

Ieranò C, Righelli D, D'Alterio C, Napolitano M, Portella L, Rea G, Auletta F, Santagata S, Trotta AM, Guardascione G, Liotti F, Prevete N, Maiolino P, Luciano A, Barbieri A, Di Mauro A, Roma C, Esposito Abate R, Tatangelo F, Pacelli R, Normanno N, Melillo RM, Scala S. Ieranò C, et al. Among authors: napolitano m. J Immunother Cancer. 2022 Mar;10(3):e004032. doi: 10.1136/jitc-2021-004032. J Immunother Cancer. 2022. PMID: 35246475 Free PMC article.

8

Human melanoma metastases express functional CXCR4.

Scala S, Giuliano P, Ascierto PA, Ieranò C, Franco R, Napolitano M, Ottaiano A, Lombardi ML, Luongo M, Simeone E, Castiglia D, Mauro F, De Michele I, Calemma R, Botti G, Caracò C, Nicoletti G, Satriano RA, Castello G. Scala S, et al. Among authors: napolitano m. Clin Cancer Res. 2006 Apr 15;12(8):2427-33. doi: 10.1158/1078-0432.CCR-05-1940. Clin Cancer Res. 2006. PMID: 16638848

9

A point mutation (G574A) in the chemokine receptor CXCR4 detected in human cancer cells enhances migration.

Ierano C, Giuliano P, D'Alterio C, Cioffi M, Mettivier V, Portella L, Napolitano M, Barbieri A, Arra C, Liguori G, Franco R, Palmieri G, Rozzo C, Pacelli R, Castello G, Scala S. Ierano C, et al. Among authors: napolitano m. Cell Cycle. 2009 Apr 15;8(8):1228-37. doi: 10.4161/cc.8.8.8250. Epub 2009 Apr 23. Cell Cycle. 2009. PMID: 19305148

10

Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcome.

Calemma R, Ottaiano A, Trotta AM, Nasti G, Romano C, Napolitano M, Galati D, Borrelli P, Zanotta S, Cassata A, Castello G, Iaffaioli VR, Scala S. Calemma R, et al. Among authors: napolitano m. J Transl Med. 2012 Nov 21;10:232. doi: 10.1186/1479-5876-10-232. J Transl Med. 2012. PMID: 23171437 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

991 results

Search Page

Filters